Revenue - Genfit SA (NASDAQ:GNFT) - Alpha Spread

Genfit SA
NASDAQ:GNFT

Watchlist Manager
Genfit SA Logo
Genfit SA
NASDAQ:GNFT
Watchlist
Price: 4.19 USD -3.46% Market Closed
Market Cap: 209.5m USD
Have any thoughts about
Genfit SA?
Write Note

Genfit SA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genfit SA
Revenue Peer Comparison

Comparables:
VLA
NANO
IPH
ALERS
OSE

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Genfit SA
NASDAQ:GNFT
Revenue
€38.2m
CAGR 3-Years
70%
CAGR 5-Years
38%
CAGR 10-Years
20%
Valneva SE
PAR:VLA
Revenue
€221.6m
CAGR 3-Years
26%
CAGR 5-Years
15%
CAGR 10-Years
20%
Nanobiotix SA
PAR:NANO
Revenue
€30.1m
CAGR 3-Years
744%
CAGR 5-Years
204%
CAGR 10-Years
67%
Innate Pharma SA
PAR:IPH
Revenue
€24.9m
CAGR 3-Years
-10%
CAGR 5-Years
-26%
CAGR 10-Years
11%
Eurobio Scientific SA
PAR:ALERS
Revenue
€130m
CAGR 3-Years
-12%
CAGR 5-Years
21%
CAGR 10-Years
16%
OSE Immunotherapeutics SA
PAR:OSE
Revenue
€2.2m
CAGR 3-Years
-40%
CAGR 5-Years
-38%
CAGR 10-Years
N/A

See Also

What is Genfit SA's Revenue?
Revenue
38.2m EUR

Based on the financial report for Dec 31, 2023, Genfit SA's Revenue amounts to 38.2m EUR.

What is Genfit SA's Revenue growth rate?
Revenue CAGR 10Y
20%

Over the last year, the Revenue growth was 44%. The average annual Revenue growth rates for Genfit SA have been 70% over the past three years , 38% over the past five years , and 20% over the past ten years .

Back to Top